PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27791160-1	2016	Dopamine (DA) promotes wakefulness, and DA transporter inhibitors such as dextroamphetamine and methylphenidate are effective for increasing arousal and inducing reanimation, or active emergence from general anesthesia.	Dextroamphetamine	74-91	solute carrier family 6 (neurotransmitter transporter, dopamine), member 3	Mus musculus	40-54	
11797063-3	2001	OBJECTIVES: The goal of the present study was to investigate the effects of acute and daily administration of d-amphetamine on the locomotor activity of DAT(-/-) mice and examine the development of behavioral sensitization.	Dextroamphetamine	110-123	solute carrier family 6 (neurotransmitter transporter, dopamine), member 3	Mus musculus	153-156	
11797063-7	2001	RESULTS: Acute and repeated d-amphetamine injection (1 mg/kg) induced an hypolocomotor response in DAT(-/-) and DAT(+/-) mice, but only DAT(+/-) mice developed locomotor sensitization to the drug.	Dextroamphetamine	28-41	solute carrier family 6 (neurotransmitter transporter, dopamine), member 3	Mus musculus	99-102	
11797063-7	2001	RESULTS: Acute and repeated d-amphetamine injection (1 mg/kg) induced an hypolocomotor response in DAT(-/-) and DAT(+/-) mice, but only DAT(+/-) mice developed locomotor sensitization to the drug.	Dextroamphetamine	28-41	solute carrier family 6 (neurotransmitter transporter, dopamine), member 3	Mus musculus	112-115	
11797063-7	2001	RESULTS: Acute and repeated d-amphetamine injection (1 mg/kg) induced an hypolocomotor response in DAT(-/-) and DAT(+/-) mice, but only DAT(+/-) mice developed locomotor sensitization to the drug.	Dextroamphetamine	28-41	solute carrier family 6 (neurotransmitter transporter, dopamine), member 3	Mus musculus	112-115	
11797063-9	2001	The common hypolocomotor effect induced by d-amphetamine and fluoxetine in DAT(-/-) mice suggests an action on the serotonin transporter.	Dextroamphetamine	43-56	solute carrier family 6 (neurotransmitter transporter, dopamine), member 3	Mus musculus	75-78	
11797063-11	2001	CONCLUSIONS: These findings indicate that partial or total DAT gene deletion result in decreased locomotion in response to d-amphetamine and modify behavioral sensitization depending on the proportion of DAT removed, suggesting that inhibition of the DAT is necessary for the development of sensitization to psychostimulant drugs.	Dextroamphetamine	123-136	solute carrier family 6 (neurotransmitter transporter, dopamine), member 3	Mus musculus	59-62